BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Duchenne muscular dystrophy

  Safety Questions Loom in Duchenne as Dyne, Wave and Others Plan FDA Filings

  Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

  March 27, 2025

   · 

  8 min read

   · 

  Heather McKenzie
• 

  Lung cancer

  J&J’s Lung Cancer Combo Bests AstraZeneca’s Tagrisso, Reducing Risk of Death 25%

  The latest data from Johnson and Johnson’s Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso on overall survival. But analysts say the next step is getting a subcutaneous formula approved.

  March 27, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Job Trends

  7 Companies Hiring in Indiana

  Looking for a biopharma job in Indiana? Check out the BioSpace list of seven companies hiring life sciences professionals like you.

  March 27, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Approvals

  Soleno Wins First FDA Approval for Hyperphagia in Prader-Willi Syndrome

  Soleno’s Vykat XR is the first drug approved for the rare disease that directly targets its hallmark symptom.

  March 27, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Mergers & acquisitions

  Alcon Secures Majority Stake in Aurion, Deposes CEO

  Last month, Deerfield Management accused Alcon of obstructing Aurion’s IPO plans so it could acquire the startup “at a discount.”

  March 27, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• 

  Policy

  RFK Jr. to Cut 10,000 Jobs Across HHS

  The announcement by the Department of Health and Human Services highlighted a flurry of moves, which include the shifting of departments. Also this week, HHS Secretary Robert F. Kennedy Jr. tapped fellow vaccine critic David Geier to investigate vaccine safety within the CDC.

  March 27, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Clinical research

  Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’

  Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

  March 27, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  IN PARTNERSHIP WITH DIA

  Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials

  In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.

  March 27, 2025

   · 

  1 min read

   · 

  Lori Ellis
• 

  Job Trends

  Biopharma Employees’ Confidence in Employers Dips Month-Over-Month in February

  Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year over year in February, according to the Glassdoor Employee Confidence Index. Glassdoor’s findings align with recent BioSpace data.

  March 27, 2025

   · 

  2 min read

   · 

  Angela Gabriel
• Press Releases

  Thryv Therapeutics to Participate in the 2025 Piper Sandler Virtual Cardio Day

  March 27, 2025

   · 

  1 min read